Combined Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy, Thalassemia and Hereditary Deafness in 2873 Chinese Pregnant Women

Author:

Wang Zhihui1,LI yuanyan,Wu jieli,cai xiaohe,chen ruyang,Zhang Lixiang

Affiliation:

1. Wenzhoushi zhongxin yiyuan: Wenzhou Central Hospital

Abstract

Abstract Purpose To investigate the clinical significance of combined carrier screening and prenatal diagnosis for SMA, thalassemia and hereditary deafness. Methods There were 2873 pregnant women from Wenzhou Central Hospital in Wenzhou city Zhejiang Province, China, between February 2020 and January 2022 accepted carrier screening. Genomic DNA was extracted from saliva of the screened group. SMN1 exon 7 and/or 8 mutations were detected by real-time quantitative PCR; results were confirmed by multiplex ligation-dependent probe amplification. α- and β-globin gene mutations and hereditary deafness gene mutations were detected using PCR and flow-through hybridization techniques. DNA-based prenatal diagnosis was performed on amniotic fluid when parents both carried at least one gene mutation of the three diseases. Prenatal diagnosis was performed for 22 at-risk fetuses. Results Among 2873 pregnant women, 419 carried at least one allele associated with the three diseases (14.6%, 419/2873); 70 (2.4%) of these carried SMA alleles, 245 (8.5%) thalassemia genes, and 127 (4.4%) deafness genes. The positive rate of combined carrier screening was higher than that of a single gene test (SMA, 6.1X higher 14.6%/2.4%; thalassemia, 1.7X higher, 14.6%/8.5%; hereditary deafness, 3.3X higher 14.6%/4.4%). After detailed genetic counseling, 350 paternal partners (84%, 350/419) were tested for corresponding mutations. Three couples were SMA carriers, 14 couples were thalassemia carriers, and 5 couples were hereditary deafness gene carriers. All 22 couples underwent prenatal diagnosis; At last, 1 fetus confirmed with SMA, two with α-­thalassemia major and one with hereditary deafness. Conclusion Combined carrier screening for these three genetic diseases improves screening efficiency, increases the positive detection rate and reduces economic expenditure. We recommend a combined antenatal screening program to prevent SMA, thalassemia major and hereditary deafness at birth.

Publisher

Research Square Platform LLC

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3